Miss Nadezhda Shnalieva

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)

Follow

Contributor content

Evaluation of preclinical atherosclerosis in chronic myeloid patients continuously treated with tyrosine kinase inhibitors

Presentation

Evaluation of preclinical atherosclerosis in chronic myeloid patients continuously treated with tyrosine kinase inhibitors

ESC 365 is supported by

novartis

Explore sponsored resources